We train professionals to see quality not as a checklist but as a mindset

Prof. Dr Syed S. Abbas, Director, Institute of Good Manufacturing Practices India (IGMPI), explains how globally benchmarked programmes, hands-on learning, industry-aligned curricula, and flexible training models are preparing professionals to meet global compliance expectations and strengthen India's position as a hub for safe, high-quality pharma products, in an interaction with Kalyani Sharma

- 

How does IGMPI's training ecosystem directly address the root causes of patient-safety lapses such as weak documentation, manufacturing deviations, and gaps in pharmacovigilance within India's pharma and healthcare sectors?

If we look closely, most patient-safety failures don't happen overnight. They start small, maybe a missed entry in a logbook, a deviation that isn't fully documented, or a followup on an adverse reaction that's delayed. At IGMPI, our programmes are designed around addressing exactly these weak points.

We train professionals to see quality not as a checklist but as a mindset. Modules on good documentation practices, data integrity, deviation handling, and CAPA make participants understand why precision matters at every step. Similarly, our pharmacovigilance courses build the skills needed to monitor drugs even after they're out in the market, ensuring that any risk is caught early. When professionals learn to connect each step of compliance with the larger picture of patient safety, they make fewer mistakes and when they do, they know how to respond effectively. That's the culture we try to build through our training ecosystem.

IGMPI's programmes are benchmarked to USFDA, EMA, WHO, and ICH guidelines. Could you elaborate on how aligning with these global standards helps Indian professionals meet international compliance expectations and support India's export readiness?